» Articles » PMID: 20521926

Are Anti-infectious Vaccinations Safe and Effective in Patients with Autoimmunity?

Overview
Journal Int Rev Immunol
Publisher Informa Healthcare
Date 2010 Jun 5
PMID 20521926
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Vaccinations have been traditionally considered a risk factor for the induction/reactivation of autoimmune diseases. A Medline search through key words "vaccinations and autoimmune diseases" from 1947 through December 2009 was conducted. Until now, vaccination effects in autoimmune diseases have only been studied in over 5000 patients. Vaccinations generally did not induce worsening of disease activity in patients with multiple sclerosis, systemic lupus erythematosus, rheumatoid arthritis, insulin-dependent-diabetes-mellitus, chronic arthritis in children, vasculitides, and myasthenia gravis, whereas immunogenicity, although protective, was generally lower than in normal controls, depending on disease severity and immunosuppressive therapy. Data are very poor on the efficacy.

Citing Articles

The Third Dose of BNT162b2 COVID-19 Vaccine Does Not "Boost" Disease Flares and Adverse Events in Patients with Rheumatoid Arthritis.

Picchianti Diamanti A, Navarra A, Cuzzi G, Aiello A, Salemi S, Di Rosa R Biomedicines. 2023; 11(3).

PMID: 36979666 PMC: 10045021. DOI: 10.3390/biomedicines11030687.


Anti-COVID-19 Vaccination in Patients with Autoimmune-Autoinflammatory Disorders and Primary/Secondary Immunodeficiencies: The Position of the Task Force on Behalf of the Italian Immunological Societies.

DAmelio R, Asero R, Cassatella M, Lagana B, Lunardi C, Migliorini P Biomedicines. 2021; 9(9).

PMID: 34572349 PMC: 8465958. DOI: 10.3390/biomedicines9091163.


Myasthenia gravis and infectious disease.

Gilhus N, Romi F, Hong Y, Skeie G J Neurol. 2018; 265(6):1251-1258.

PMID: 29372387 DOI: 10.1007/s00415-018-8751-9.


Safety and immunogenicity of co-administered MF59-adjuvanted 2009 pandemic and plain 2009-10 seasonal influenza vaccines in rheumatoid arthritis patients on biologicals.

Milanetti F, Germano V, Nisini R, Donatelli I, Di Martino A, Facchini M Clin Exp Immunol. 2014; 177(1):287-94.

PMID: 24666311 PMC: 4089179. DOI: 10.1111/cei.12292.


Infection risk in rheumatoid arthritis and spondyloarthropathy patients under treatment with DMARDs, corticosteroids and TNF-α antagonists.

Germano V, Cattaruzza M, Osborn J, Tarantino A, Di Rosa R, Salemi S J Transl Med. 2014; 12:77.

PMID: 24655394 PMC: 3994399. DOI: 10.1186/1479-5876-12-77.